John M Kent

US Patent:

20080177612, Jul 24, 2008

Filed:

Jan 24, 2008

Appl. No.:

12/019491

Inventors:

Jean Paul Pascual Starink - San Jose CA, US
John Thomas Kent - Saratoga CA, US

International Classification:

G06Q 10/00
G06F 7/00

US Classification:

705 8, 235376

Abstract:

A method and system for designing, storing, and executing workflows for laboratory processes have been disclosed. According to one embodiment, a computer-implemented method, comprises executing a workflow. The workflow includes a process activity, a system activity, and a flow control activity. A first user interface is adapted to collect one or more process elements for the process activity. The process activity is collected with form elements, the form elements identifying containers. The containers include plates, tubes, and bottles holding samples. States are associated with the samples and containers. The states are automatically changed as the workflow is completed. A second user interface is provided to create a customized workflow.

US Patent:

46751890, Jun 23, 1987

Filed:

Feb 8, 1985

Appl. No.:

6/699715

Inventors:

John S. Kent - Cupertino CA
Danny H. Lewis - Birmingham AL
Lynda M. Sanders - Palo Alto CA
Thomas R. Tice - Birmingham AL

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 950

US Classification:

424490

Abstract:

This invention concerns novel sustained release microcapsule compositions comprising water-soluble, hormonally active polypeptides and, optionally, a polymer hydrolysis modifying agent encapsulated in a biocompatible, biodegradable polymer.

US Patent:

41805607, Dec 25, 1979

Filed:

May 5, 1978

Appl. No.:

5/903284

Inventors:

Martin Katz - Los Altos Hills CA
John S. Kent - Palo Alto CA

Assignee:

Syntex Corporation - Palo Alto CA

International Classification:

A61K 922
A61K 924

US Classification:

424 21

Abstract:

A novel spherical implant pellet containing estradiol, estradiol benzoate, or mixtures thereof as the sole active ingredients which exhibits a substantially constant drug release rate over a timer period and substantially abrupt termination of drug release at the end of the time period is prepared which has an inert spherical core of a diameter of about 2-10 mm and a uniform coating of about 0. 05-1 mm completely covering the core, the coating comprising about 5-99% suitable carrier and 1-95% drug. A drug may be administered at a constant rate over a chosen period by implanting the novel pellet and the release is substantially abruptly terminated at the end of said period without removing the pellet.

US Patent:

44527756, Jun 5, 1984

Filed:

Dec 3, 1982

Appl. No.:

6/446749

Inventors:

John S. Kent - Palo Alto CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 926
A61K 3156
A61K 3702
A61K 3726

US Classification:

424 19

Abstract:

Delivery systems for releasing macromolecular active agents to a body site at a controlled rate for a prolonged period of time, comprising a cholesteric matrix permeable to passage of the macromolecular active agent by diffusion, are disclosed. The cholesteric matrix comprises cholesterol powder and cholesterol prills optionally in combination with a binding agent and a lubricating agent. The macromolecular active agent is dispersed throughout the matrix; macromolecules suitable for release from this delivery system have molecular weights of about 1300 to about 75,000 and are at least very slightly soluble in water.

US Patent:

43894143, Jun 21, 1983

Filed:

May 11, 1981

Appl. No.:

6/262102

Inventors:

John S. Kent - Cupertino CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 31235

US Classification:

424308

Abstract:

The mixture of polyethylene glycol having a molecular weight of about 380 to about 630 with the prostaglandins dl-9. alpha. ,11. alpha. ,15. alpha. -trihydroxy-16-phenoxy-17,18,19,20-tetranor prosta-4,5,13-trans-trieneoic acid and the lower alkyl esters thereof are useful for parenteral administration to mammals as luteolytic agent, primarily for inducing abortion.

US Patent:

40962393, Jun 20, 1978

Filed:

Oct 26, 1976

Appl. No.:

5/735727

Inventors:

Martin Katz - Los Altos Hills CA
John S. Kent - Palo Alto CA

Assignee:

Syntex Corporation

International Classification:

A61K 922
A61K 31565

US Classification:

424 21

Abstract:

A novel spherical implant pellet containing estradiol, estradiol benzoate, or mixtures thereof as the sole active ingredients which exhibits a substantially constant drug release rate over a timer period and substantially abrupt termination of drug release at the end of the time period is prepared which has an inert spherical core of a diameter of about 2-10 mm and a uniform coating of about 0. 05-1 mm completely covering the core, the coating comprising about 5-99% suitable carrier and 1-95% drug. A drug may be administered at a constant rate over a chosen period by implanting the novel pellet and the release is substantially abruptly terminated at the end of said period without removing the pellet.